Your browser doesn't support javascript.
loading
Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer.
Hannan, Raquibul; McLaughlin, Mark F; Pop, Laurentiu M; Pedrosa, Ivan; Kapur, Payal; Garant, Aurelie; Ahn, Chul; Christie, Alana; Zhu, James; Wang, Tao; Robles, Liliana; Durakoglugil, Deniz; Woldu, Solomon; Margulis, Vitaly; Gahan, Jeffrey; Brugarolas, James; Timmerman, Robert; Cadeddu, Jeffrey.
Afiliación
  • Hannan R; Department of Radiation Oncology, University of Texas Southwestern, Dallas, TX, USA; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: Raquibul.Hannan@utsouthwestern.edu.
  • McLaughlin MF; Department of Radiation Oncology, University of Texas Southwestern, Dallas, TX, USA.
  • Pop LM; Department of Radiation Oncology, University of Texas Southwestern, Dallas, TX, USA.
  • Pedrosa I; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Radiology, University of Texas Southwestern, Dallas, TX, USA; Department of Urology, University of Texas Southwestern, Dallas, TX, USA.
  • Kapur P; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Urology, University of Texas Southwestern, Dallas, TX, USA; Department of Pathology, University of Texas Southwestern, Dallas, TX, USA.
  • Garant A; Department of Radiation Oncology, University of Texas Southwestern, Dallas, TX, USA; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Ahn C; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Population and Data Sciences, University of Texas Southwestern, Dallas, TX, USA.
  • Christie A; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Zhu J; Quantitative Biomedical Research Center, Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Wang T; Quantitative Biomedical Research Center, Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Robles L; Department of Radiation Oncology, University of Texas Southwestern, Dallas, TX, USA.
  • Durakoglugil D; Department of Radiation Oncology, University of Texas Southwestern, Dallas, TX, USA.
  • Woldu S; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Urology, University of Texas Southwestern, Dallas, TX, USA.
  • Margulis V; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Urology, University of Texas Southwestern, Dallas, TX, USA.
  • Gahan J; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Urology, University of Texas Southwestern, Dallas, TX, USA.
  • Brugarolas J; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Internal Medicine, University of Texas Southwestern, Dallas, TX, USA.
  • Timmerman R; Department of Radiation Oncology, University of Texas Southwestern, Dallas, TX, USA; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Cadeddu J; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Urology, University of Texas Southwestern, Dallas, TX, USA.
Eur Urol ; 84(3): 275-286, 2023 09.
Article en En | MEDLINE | ID: mdl-36898872

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Radiocirugia / Neoplasias Renales Tipo de estudio: Clinical_trials / Observational_studies Límite: Humans Idioma: En Revista: Eur Urol Año: 2023 Tipo del documento: Article Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Radiocirugia / Neoplasias Renales Tipo de estudio: Clinical_trials / Observational_studies Límite: Humans Idioma: En Revista: Eur Urol Año: 2023 Tipo del documento: Article Pais de publicación: Suiza